Boothbay Fund Management’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-1,123
| Closed | -$65K | – | 2208 |
|
2022
Q1 | $65K | Hold |
1,123
| – | – | ﹤0.01% | 1767 |
|
2021
Q4 | $81K | Sell |
1,123
-3,140
| -74% | -$226K | ﹤0.01% | 1570 |
|
2021
Q3 | $345K | Sell |
4,263
-1,050
| -20% | -$85K | 0.01% | 1050 |
|
2021
Q2 | $512K | Buy |
5,313
+1,006
| +23% | +$96.9K | 0.02% | 863 |
|
2021
Q1 | $517K | Buy |
4,307
+2,391
| +125% | +$287K | 0.02% | 753 |
|
2020
Q4 | $251K | Hold |
1,916
| – | – | 0.01% | 859 |
|
2020
Q3 | $202K | Buy |
+1,916
| New | +$202K | 0.01% | 816 |
|